Clinical Trials Browser

Phase 1 × Leukemia, Lymphoid × Receptors, Chimeric Antigen × Clear all

NCT05507827 2025-09-16

Myeloablative Conditioning Orca-T & Allogeneic Donor-Derived CD19/CD22-CAR TCells in B-Cell ALL

Phase 1 Active not recruiting

Other hematologic neoplasm

Leukemia, Lymphoid